University Hospital, Grenoble
chu-grenoble.frTotal trials
812
Active
164
Phase 3
51
Total enrollment
321,966
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 24 of 24 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Individualization of first voriconazole maintenance doses | — | — | — | — | — | 1 | |
| L-citrulline | — | — | — | — | — | 1 | |
| Propofol-Lipuro | — | — | — | — | — | 1 | |
| Placebos | — | — | — | — | — | 1 | |
| Volatile anesthetic | — | — | — | — | — | 1 | |
| Opioid Anesthesia | — | — | — | — | — | 1 | |
| 68Ga-DOTATOC | — | — | — | — | — | 1 | |
| embolization therapy | — | — | — | — | — | 1 | |
| oral administration of midazolam or placebo | — | — | — | — | — | 1 | |
| Morphine hydrochloride | — | — | — | — | — | 1 | |
| Atezolizumab | — | — | — | — | 2 | ||
| Bevacizumab | — | — | — | — | 2 | ||
| NP137 | — | — | — | — | — | 2 | |
| Adipose derived Stem Cell | — | — | — | — | — | 1 | |
| Blood test | — | — | — | — | 2 | ||
| Dosage Forms | — | — | — | — | — | 1 | |
| Isoflurane | — | — | — | — | — | 1 | |
| Stool samples | — | — | — | — | — | 1 | |
| Isolation of anti-Pseudomonas antibodies from type B lymphocytes | — | — | — | — | — | 1 | |
| Blood test 4 EDTA tubes | — | — | — | — | — | 1 | |
| Characterization of early biological effects following exposure to PAHs | — | — | — | — | — | 1 | |
| Urea | — | — | — | — | — | 1 | |
| Enoxaparin standard dose | — | — | — | — | — | 1 | |
| Enoxaparin intermediate dose | — | — | — | — | — | 1 |
Next readouts
- 2024-03-18
- 2024-12-03
- 2025-07-01
- 2025-10
- 2025-10
- 2026-01-25
- 2026-03-19
- 2026-06-01
- 2026-06-20
- 2026-08-01
Top conditions
- Parkinson Disease20
- Obstructive Sleep Apnea18
- Healthy Volunteers16
- Healthy15
- Obstructive Sleep Apnea Syndrome12
- Stroke11
- Healthy Volunteer10
- Obesity9
Frequently asked questions about University Hospital, Grenoble
- How many clinical trials does University Hospital, Grenoble have on ClinicalTrials.gov?
- University Hospital, Grenoble is listed as the lead sponsor on 812 clinical trials in ClinicalTrials.gov, 164 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University Hospital, Grenoble's trials are in Phase 3?
- 51 of University Hospital, Grenoble's trials are in Phase 3, spread across 24 active drug programs.
- What therapeutic areas does University Hospital, Grenoble focus on?
- University Hospital, Grenoble's most-studied conditions on ClinicalTrials.gov are Parkinson Disease, Obstructive Sleep Apnea, Healthy Volunteers, Healthy, Obstructive Sleep Apnea Syndrome.
- When are University Hospital, Grenoble's next clinical trial readouts?
- University Hospital, Grenoble has 10 upcoming primary-completion readouts tracked here; the soonest is “Respiratory Effect of the LISA Method with Sedation by Propofol Versus Absence of Sedation.”, expected around 2024-03-18.